AstraZeneca Recentin failed
AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
The mixed news on Wednesday adds to the company’s patchy record on drug research, analysts said.
Recentin, which is given as a pill, is [...]